Edarbyclor
formulated to alleviate high blood pressure through dual mechanisms.
Strengths: 40/12.5mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Azilsartan and Chlorthalidone Tablets
- Therapeutic class
Angiotensin II Receptor Antagonist; Thiazide-like Diuretic
- Pharmacological class
ARB; Thiazide-like Diuretic
- Contraindications
hypersensitivity to sulfonamides; anuria; severe renal impairment
- Minor side effects
dizziness; fatigue
- Moderate side effects
hypotension; hyperuricaemia
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
formulated to alleviate high blood pressure through dual mechanisms.
- Prescription status
POM
- Manufacturer
Takeda Pharmaceutical
- Onset Time
1–2 weeks
- Duration
24 hours
- Storage instructions
Store in a cool, dry place.
- Drug interactions
lithium; NSAIDs
- Age restrictions
Not for use in children.
Precautions and warnings
monitor electrolyte levels; maintain adequate hydration; regular kidney function testing
Serious side effects
angioedema — requires immediate medical attention; renal failure — requires immediate medical attention
Mechanism of action
Azilsartan blocks the action of angiotensin II to relax blood vessels, while chlorthalidone increases renal excretion of sodium and water, effectively lowering systemic blood pressure.
Pregnancy and breastfeeding
Pregnancy: Discontinue treatment immediately if pregnancy is detected. Breastfeeding: Not recommended.
Edarbyclor
formulated to alleviate high blood pressure through dual mechanisms.
Editorial Notes
- Active ingredient(s): Azilsartan, Chlorthalidone
- Listed indication(s): Hypertension
Available option
- 90 tablets - 40/12.5 mg1045-40-12-5-mg-13200